Thermo Fisher Scientific to Report Second-Quarter Earnings July 23

July 2, 2025

— Jeff Ward, Lehigh Valley News Briefs

Thermo Fisher Scientific, a maker of medical and laboratory equipment, will report second-quarter earnings July 23.

The Waltham, Massachusetts-based company will hold a conference call that day at 8:30 a.m.

Thermo Fisher Chief Executive Officer Marc N. Casper is usually upbeat during the calls, but the stock (NYSE:TMO) has been a laggard for years.

At 12:24 p.m. today (July 2), shares were trading at $426.06, well below the highs reached during the Covid-19 pandemic. The dividend yield is a meager 0.4%.

The company has operations in the Lehigh Valley.

— Disclosure: I own this stock, to my regret. It has shown some pop in the last couple days, but I should have dropped it a long time ago.

Here’s a cut-and-paste version of their statement:

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2025 before the market opens on Wednesday, July 23, 2025, and will hold a conference call on the same day at 8:30 a.m. ET.

During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. The access code is 523661. You may also listen to the call live on the “Investors” section of our website, www.thermofisher.com. The earnings press release and related information can also be found in that section of our website under the heading “Financials.” A replay of the call recording will be available under “News, Events & Presentations” through Tuesday, October 21, 2025.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.